Abiopharma

🔍 Broadfoot Jill Marie (Executive)

Company: TALPHERA, INC. (TLPH)

Report Date: 2025-10-23

Detailed Transactions and Holdings:

• Acquired 4,267 shares of Common Stock (Direct)
  Date: 2025-10-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,547.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 25,600 shares of Stock Option (Right to Buy) at $1.14 per share (Derivative)
  Date: 2025-10-23 | Code: A | Expires: 2035-10-22 | equity_swap_involved: 0 | shares_owned_after: 25,600.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
• F3: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.